Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 2 |
2016 | 1 |
2017 | 1 |
2018 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Iron as a therapeutic target for Parkinson's disease.
Mov Disord. 2018 Apr;33(4):568-574. doi: 10.1002/mds.27275. Epub 2018 Jan 30.
Mov Disord. 2018.
PMID: 29380903
Review.
No abstract available.
Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?
Moreau C, Danel V, Devedjian JC, Grolez G, Timmerman K, Laloux C, Petrault M, Gouel F, Jonneaux A, Dutheil M, Lachaud C, Lopes R, Kuchcinski G, Auger F, Kyheng M, Duhamel A, Pérez T, Pradat PF, Blasco H, Veyrat-Durebex C, Corcia P, Oeckl P, Otto M, Dupuis L, Garçon G, Defebvre L, Cabantchik ZI, Duce J, Bordet R, Devos D.
Moreau C, et al.
Antioxid Redox Signal. 2018 Sep 10;29(8):742-748. doi: 10.1089/ars.2017.7493. Epub 2018 Feb 8.
Antioxid Redox Signal. 2018.
PMID: 29287521
Free PMC article.
Clinical Trial.
Item in Clipboard
Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson's disease.
Duce JA, Wong BX, Durham H, Devedjian JC, Smith DP, Devos D.
Duce JA, et al.
Mol Neurodegener. 2017 Jun 7;12(1):45. doi: 10.1186/s13024-017-0186-8.
Mol Neurodegener. 2017.
PMID: 28592304
Free PMC article.
Review.
Item in Clipboard
Bioavailable Trace Metals in Neurological Diseases.
Poujois A, Devedjian JC, Moreau C, Devos D, Chaine P, Woimant F, Duce JA.
Poujois A, et al.
Curr Treat Options Neurol. 2016 Oct;18(10):46. doi: 10.1007/s11940-016-0426-1.
Curr Treat Options Neurol. 2016.
PMID: 27682263
Free article.
Review.
Item in Clipboard
Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators.
Workman DG, Tsatsanis A, Lewis FW, Boyle JP, Mousadoust M, Hettiarachchi NT, Hunter M, Peers CS, Tétard D, Duce JA.
Workman DG, et al.
Metallomics. 2015 May;7(5):867-76. doi: 10.1039/c4mt00326h. Epub 2015 Mar 17.
Metallomics. 2015.
PMID: 25781076
Free article.
Item in Clipboard
Parkinson's disease iron deposition caused by nitric oxide-induced loss of β-amyloid precursor protein.
Ayton S, Lei P, Hare DJ, Duce JA, George JL, Adlard PA, McLean C, Rogers JT, Cherny RA, Finkelstein DI, Bush AI.
Ayton S, et al.
J Neurosci. 2015 Feb 25;35(8):3591-7. doi: 10.1523/JNEUROSCI.3439-14.2015.
J Neurosci. 2015.
PMID: 25716857
Free PMC article.
Item in Clipboard
Cite
Cite